Related Experiment Video
Updated: Jun 13, 2026
11:45
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
Published on: January 7, 2019
Current status of stem cell therapy in heart failure
Marta Codina1, Jeremy Elser, Kenneth B Margulies
1University of Pennsylvania School of Medicine, BRB II/III, Room 608, 421 Curie Boulevard, Philadelphia, PA 19014, USA. martaco@mail.med.upenn.edu
Current Cardiology Reports
|April 29, 2010
Summary
This review explores cardiac regeneration, focusing on new myocyte formation and repair processes. It highlights cell therapy and tissue engineering as complementary strategies for heart repair after injury.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Cardiac Physiology
Background:
- Adult mammalian hearts show potential for new myocyte formation.
- Endogenous cardiac repair mechanisms are often insufficient after myocardial infarction and heart failure.
- Research is advancing the understanding of cardiac myogenesis and angiogenesis.
Purpose of the Study:
- To review evidence for endogenous cardiac repair in humans.
- To discuss progress in clinical myocardial cell therapy.
- To explore tissue engineering strategies for manipulating myocardial repair.
Main Methods:
- Literature review of cardiac regeneration studies.
- Analysis of clinical trials in myocardial cell therapy.
- Examination of tissue engineering approaches for cardiac repair.
Main Results:
- Endogenous repair mechanisms are insufficient alone.
- Cell therapy shows promise but requires further development.
- Tissue engineering offers complementary strategies to enhance repair.
Conclusions:
- Combining insights from endogenous repair, cell therapy, and tissue engineering is crucial.
- A multifaceted approach is needed for effective therapeutic cardiac regeneration.
- Future strategies should integrate these complementary lines of inquiry for optimal outcomes.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...